Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
Phase 2
Active, not recruiting
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Drug: Antimicrobial Peptide PL-5 Topical Spray and Placebo
- First Posted Date
- 2024-01-03
- Last Posted Date
- 2025-05-25
- Target Recruit Count
- 90
- Registration Number
- NCT06189638
- Locations
- 🇺🇸
ILD Research Center, Vista, California, United States
🇺🇸Bioresearch Partner Holdings, LLLP, Miami, Florida, United States
🇺🇸Santos Research Center, Corp, Tampa, Florida, United States
News
No news found